StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Factor scoring needs Finnhub-supplied fundamentals — Finnhub returned no fundamental metrics for this ticker. Common for ETFs, foreign filers without US listing depth, recent IPOs, and thinly-traded OTC names.
6-factor scoring with sector-relative rank. Updated daily.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-11 | $7.31 | $7.36 | +0.68% | 0.6M |
| 05-12 | $7.36 | $7.55 | +2.58% | 0.3M |
| 05-13 | $7.28 | $7.39 | +1.51% | 0.3M |
| 05-14 | $7.42 | $7.43 | +0.13% | 0.3M |
| 05-15 | $7.38 | $7.12 | -3.52% | 0.2M |
Aggregated from Polygon's per-article sentiment classifications. Educational — sentiment is descriptive, not predictive.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $727.76M | $475.81M | $236.10M | $853.70M |
Operating Income | $-7.53M | $21.55M | $8.29M | $-29.76M |
Net Income | $-10.82M | $18.64M | $8.02M | $-30.31M |
EPS (Diluted) | $-0.08 | $0.14 | $0.06 | $-0.22 |
Total Assets | $547.39M | $527.48M | $510.23M | $526.85M |
Total Liabilities | $288.50M | $238.72M | $234.47M | $263.94M |
Cash & Equivalents | $95.54M | $83.20M | $67.15M | $64.13M |
Free Cash Flow OCF − CapEx | $33.38M | $18.84M | $-153.00K | $26.60M |
Shares Outstanding | 135.71M | 135.70M | 135.68M | 135.44M |
No sell-side coverage available for INNV.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
Fundamentals not available for INNV.
No fundamental metrics available yet for this ticker — common for ETFs, foreign issuers without US listing depth, very recent IPOs, or thinly-traded OTC names. The Financials tab pulls from SEC EDGAR directly and may still have data.
InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. The company manages its business as one reportable segment, PACE.